http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107233354-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-746 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-55 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-702 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-702 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-746 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
filingDate | 2017-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-107233354-B |
titleOfInvention | Ophthalmic preparation for preventing and treating asthenopia, myopia and macular degeneration and preparation method thereof |
abstract | The invention discloses an ophthalmic preparation for preventing and treating asthenopia, myopia and macular degeneration and a preparation method thereof. The steps are as follows: extracting Morinda officinalis to obtain Morinda officinalis extract powder; weighing the Morinda officinalis extract powder and medicinal chlorine Add sodium bisulfite and activated carbon to the solution, boil, stir and filter; then add water for injection to adjust the pH value; filter again; product potting and sterilization. The advantages of the present invention are: Morinda officinalis extract powder contains Morinda officinalis oligosaccharides and polysaccharide compounds, which are water-soluble, and impurities are removed by water extraction and alcohol precipitation and macroporous resin to obtain oligosaccharides with higher purity. , polysaccharide compounds, Morinda officinalis extract, dissolved in water for injection, activated carbon to adsorb bacteria and viruses, adding appropriate preservatives and antioxidants, using aseptic preparation technology, subpackaged into ophthalmic preparations to achieve precise dosage of preparations. medicine. |
priorityDate | 2017-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 266.